Continuous Presence of Th1 Conditions Is Necessary for Longer Lasting Tumor-Specific CTL Activity in Stimulation Cultures With PBL

This publication has 33 references indexed in Scilit:

• Low-Dose Adenoviral Immunotherapy of Rat Hepatocellular Carcinoma Using Single-Chain Interleukin-12
  Human Gene Therapy, 2005
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
  Nature Medicine, 2004
• Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma
  Human Immunology, 2004
• Persistent Toll-like receptor signals are required for reversal of regulatory T cell–mediated CD8 tolerance
  Nature Immunology, 2004
• Specialization in tolerance: innate CD4+CD25+ versus acquired TR1 and TH3 regulatory T cells.1
  Transplantation, 2004
• Modulating Th1/Th2 Responses With Microbes, Dendritic Cells, and Pathogen Recognition Receptors
  Immunologic Research, 2004
• Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
  Immunity, 2004
• Toll-like receptors and T-helper-1/T-helper-2 responses
  Current Opinion in Infectious Diseases, 2003
• Cancer vaccines
  Nature Medicine, 1998
• Identification of human cancers deficient in antigen processing.
  The Journal of Experimental Medicine, 1993